Delivery Order SPE2DB20D3103-SPE2DB25FP7Q3
- Not listed
- The Defense Logistics Agency awarded a $2,093.98 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This firm fixed-price contract was competitively awarded without set-aside designations and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $21,107.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order is issued under a non-set-aside competitive award and represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. This competitively awarded, non-set-aside contract is classified as firm fixed price and was executed on August 22, 2025, with an ultimate completion date of August 25, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation of diazepam used for acute seizure management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $7,354.61. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,648.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of August 6, 2025. This competitive award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,678.34 for Valtoco 15 mg nasal sprays on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.10 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays. The contract, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,183.28 for Valtoco 15 mg nasal sprays on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with a contract ceiling value of $1,453.86. This competitively awarded, firm fixed-price delivery order, issued on September 5, 2025, is set to conclude by September 8, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under a larger contracting vehicle. This delivery order is...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7Q3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays valued at $2,324.61 on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price contract requires delivery to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award was made on a competitive basis without a set-aside designation, reflecting the contractor's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Valtoco, a nasal spray formulation of diazepam used for acute seizure management, supports military healthcare system requirements. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this comprehensive IDC vehicle to supply brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/6/25 |